• 专利标题:   Production of biogenic-based silver nanoparticles used for spray suspension in preparation of nasal spray, involves adding natural bioflavone hesperetin isolated to sodium hydroxide and adding silver nitrate, and neutralizing suspension using hydrochloric acid solution.
  • 专利号:   BR102020026649-A2
  • 发明人:   TASIC L, SAVU R, MOSHKALEV S, ARNS C W, CANESQUI M A, TSUKAMOTO J, STANISIC D, MAGDALENA ESPINOLA COLMAN M
  • 专利权人:   UNICAMP UNIV ESTADUAL CAMPINAS
  • 国际专利分类:   A61L002/00, B82Y030/00, B82Y040/00, C01G005/00
  • 专利详细信息:   BR102020026649-A2 05 Jul 2022 C01G-005/00 202307 Pages: 35
  • 申请详细信息:   BR102020026649-A2 BR10026649 23 Dec 2020
  • 优先权号:   BR10026649

▎ 摘  要

NOVELTY - Production of biogenic-based silver nanoparticles involves (a) adding natural bioflavone hesperetin isolated from bark from orange in a concentration of 1 mmol/L to a solution of sodium hydroxide in a concentration of 0.005 mol/L, (b) adding silver nitrate solution (A) in a concentration of 1 mmol/L to the solution of step (a) in a ratio of 1/1 (v/v) in drops, and (c) neutralizing the suspension using hydrochloric acid solution and diluting to a pH of 7.4. USE - Production of biogenic-based silver nanoparticles used for spray suspension in preparation of nasal spray or sanitizer, and for flexible nanostructured composite papers for packaging and as filters for face masks (all claimed). ADVANTAGE - The method produces biogenic-based silver nanoparticles having reduced toxicity against L929 fibroblast cells, and virucidal activity against coronavirus. DETAILED DESCRIPTION - INDEPENDENT CLAIMS are included for the following: the biogenic-based silver nanoparticles, which have an average size of 22 nm (± 8 nm), a potential of -35 mV and low polydispersity index of 0.3; a spray suspension, which comprises 50-0.05 μ mol/L biogenic based-silver nanoparticles, 0.2% glycerol and 0.01% limonene for inactivating 99.99% virus, and having virucidal activity against coronavirus and is non-toxic; and a flexible nanostructured composite papers, which comprises the graphene oxide decorated with 0.05 mmol/L silver nanoparticles and/or suspension of cellulose nanofibers treated with sodium hydroxide.